Filing Details

Accession Number:
0000899243-16-015092
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-02 21:02:12
Reporting Period:
2016-02-29
Filing Date:
2016-03-02
Accepted Time:
2016-03-02 21:02:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594864 Juno Therapeutics Inc. JUNO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1480212 Edgar Hans Bishop C/O 307 Westlake Avenue North, Suite 300
Seattle WA 98109
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-29 54,000 $6.36 2,741,359 No 4 M Direct
Common Stock Disposition 2016-02-29 86,871 $35.27 2,654,488 No 4 S Direct
Common Stock Disposition 2016-02-29 3,879 $36.46 2,650,609 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-02-29 54,000 $0.00 54,000 $6.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
893,506 2024-09-08 No 4 M Direct
Footnotes
  1. 1/48 of the shares subject to the option became vested and exercisable on October 9, 2014 and 1/48th of the shares subject to the option vested monthly thereafter.
  2. This transaction was executed in multiple trades at prices ranging from $34.78 to $35.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $35.90 to $36.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014, as amended March 20, 2015.